RadioBDC Logo
Habits (Stay High) | Tove Lo Listen Live
THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Critics worry Stewart trial won't bring major change

Lawmakers scrutinize interaction of FDA, SEC

By Ross Kerber
Globe Staff / January 12, 2004
Text size +
  • E-mail
  • E-mail this article

    Invalid E-mail address
    Invalid E-mail address

    Sending your article

    Your article has been sent.

Will the Martha Stewart case lead to major changes in the way biotechnology companies are regulated? (Full article: 922 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass